Glaxo says Advair sales to top 4 bln pounds in 2008

Wed May 21, 2008 10:07am EDT
 
[-] Text [+]

LONDON, May 21 (Reuters) - GlaxoSmithKline Plc (GSK.L), the world's second-largest drugs company by turnover, said sales of its asthma drug Advair would top 4 billion pounds ($7.9 billion) this year.

"We are going to break 4 billion of sales this year with Advair," outgoing Chief Executive Jean-Pierre Garnier told shareholders at the company's annual meeting.

Advair is Glaxo's top selling drug, and had global sales of 3.5 billion pounds in 2007. ($1=.5088 Pound) (Reporting by Ben Hirschler, editing by Will Waterman)

 
Kenneth Griffin, Founder, President and CEO, Citadel Investment Group LLC, speaks during the "Financial Recovery: When and How?" panel at the 2009 Milken Institute Global Conference in Beverly Hills, California April 27, 2009. REUTERS/Phil McCarten
Citadel enters the fray

Kenneth Griffin's powerful hedge fund has waded into the case of Goldman Sachs' purloined computer code, suing three of its former employees for setting up Teza Technologies.  Full Article | Full Coverage 

Companies In This Article

Join the Reuters Consumer Insight Panel and help us get to know you better

Join the Reuters Consumer Insight Panel and help us get to know you better